Analyzing the article from a skeptical perspective, it's important to acknowledge that while this research holds great promise for cancer therapy, there are several challenges and limitations to consider: 1. Challenges in scaling up production: As of now, creating PDOs is a labor-intensive process that requires expertise and significant resources. If the goal is to make these organoids widely available for personalized medicine, scalability will be crucial. 2. Potential ethical concerns: Given t...